Background: Nearly 50 % of all patients suffering from renal cell cancer develop metastases during the course of the disease.
Objective: The aim of this article is to describe the options for radiotherapy of metastatic renal cell carcinoma.
Material and methods: A systematic search of the literature for articles on radiotherapy of metastatic renal cell carcinoma was carried out.
Results: A new treatment option for long-term local control especially for oligometastatic patients is high-dose stereotactic radiotherapy. Local control rates are around 80 % or higher; however, moderately hypofractionated radiotherapy remains the treatment of choice for symptomatic patients with multiple brain metastases and for patients in a poor general condition with symptomatic bone or other extracranial metastases. Alleviation of symptoms is achieved in 60–80 %.